Center-Authored Papers

Filters: Author is Johnson, Bruce E  [Clear All Filters]
2017
Awad MM, Chu QS-C, Gandhi L, Stephenson JJ, Govindan R, Bradford DS, Bonomi PD, Ellison DM, Eaton KD, Fritsch H et al..  2017.  An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).. Lung cancer (Amsterdam, Netherlands). 104:126-130. Abstract
2016
Planchard D, Besse B, Groen HJM, Souquet P-J, Quoix E, Baik CS, Barlesi F, Kim TM, Mazieres J, Novello S et al..  2016.  Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.. The Lancet. Oncology. 17(7):984-93. Abstract
2008
Kalemkerian GP, Akerley W, Downey RJ, Ettinger DS, Fossella F, Grecula JC, Jahan T, Johnson BE, Kessinger A, Koczywas M et al..  2008.  Small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(3):294-314.